Danish Bladder Cancer Patients Show Similar Outcomes in Clinical Practice and Clinical Trials

Two studies evaluating all Danish patients with bladder cancer treated with first-line chemotherapy and all-line pembrolizumab, respectively, have found similar outcomes and overall survival rates between patients treated in clinical practice and those from clinical trials.